Parkinson’s
NR Times explores the latest research developments in the world of neurorehabilitation Brain stimulation improves vision recovery after stroke Hemianopia is a condition that causes loss of half of the visual field (the “vertical midline”), which can happen following stroke and can severely affect daily activities such as reading, driving, or just walking through a [...]
A simple walking test that times how quickly people turn could flag Parkinson's nearly nine years before diagnosis. The finding could help spot patients in the prodromal phase – the earliest stage when brain damage starts but symptoms are subtle. This window can last years before tremor and movement problems prompt diagnosis. The [...]
A smartphone platform that helps doctors monitor Parkinson’s symptoms has raised US$5.6m to expand its commercial capacity and advance dementia-monitoring technology. The funding brings total investment to US$11.2m for the clinically validated system, which uses smartphones to track changes in movement, speech and cognition. Kneu Health’s platform includes a tremor measurement tool cleared by the [...]
Researchers have directly seen and measured the protein clusters thought to spark Parkinson’s disease for the first time, marking a major milestone in understanding the condition. These microscopic clusters, known as alpha-synuclein oligomers, have long been suspected as the starting point for Parkinson’s but had remained undetectable in human brain tissue until now. A team [...]
A woman with Parkinson’s disease played the clarinet during brain surgery, allowing doctors to observe immediate improvements in her movement. Denise Bacon, 65, from Crowborough in East Sussex, underwent Deep Brain Stimulation (DBS) at King’s College Hospital while awake. Her playing helped surgeons assess the success of the procedure in real time. DBS involves implanting [...]
NR Times explores the latest business and pharmaceutical developments in the world of neurorehabilitation. New partnership to distribute of MedRhythms devices for stroke and Parkinson’s Neurorehabilitation company MedRhythms has entered a strategic partnership with Edwards Health Care Services (EHCS), a leading provider of direct-to-home medical products. The partnership enables nationwide distribution of MedRhythms' currently available [...]
People with Parkinson’s are receiving a new investigational treatment after a successful study demonstrated the therapy’s safety in non-human primates and refined the method for its delivery. Biotechnology company Aspen Neuroscience said it would enrol a third group of participants in its ASPIRO trial after the first four patients safely tolerated the therapy. The Phase [...]
Emerging research is exploring the potential of photobiomodulation (PBM) - a light-based therapy targeting the gut-brain axis- as a promising new treatment for Parkinson’s disease. A recently published clinical trial, conducted on 60 participants in Canada, reported clinically significant improvements in multiple Parkinson’s symptoms following treatment with photobiomodulation (PBM) therapy. The results, presented last month at [...]
Martial arts classes are transforming the lives of people living with neurological conditions such as multiple sclerosis (MS) and Parkinson’s disease. NR Times editor Stephanie Price speaks to Adam Poulter, founder of Foundation Physio, to find out more. Neurophysiotherapy service Foundation Physio is helping its clients to build strength, flexibility and co-ordination through a ten-week [...]
NR Times explores the latest research developments in the world of neurology and neurorehabilitation. Scientists reverse Alzheimer’s in mice using nanoparticles Researchers have demonstrated a nanotechnology strategy that reverses Alzheimer’s disease in mice. Unlike traditional nanomedicine, which relies on nanoparticles as carriers for therapeutic molecules, this approach employs nanoparticles that are bioactive in their own [...]
